Cargando…

A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation

The blood-brain barrier (BBB) serves to protect and regulate the CNS microenvironment. The development of an in-vitro mimic of the BBB requires recapitulating the correct phenotype of the in-vivo BBB, particularly for drug permeation studies. However the majority of widely used BBB models demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbakary, Basma, Badhan, Raj K. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052153/
https://www.ncbi.nlm.nih.gov/pubmed/32123236
http://dx.doi.org/10.1038/s41598-020-60689-w
_version_ 1783502809028624384
author Elbakary, Basma
Badhan, Raj K. S.
author_facet Elbakary, Basma
Badhan, Raj K. S.
author_sort Elbakary, Basma
collection PubMed
description The blood-brain barrier (BBB) serves to protect and regulate the CNS microenvironment. The development of an in-vitro mimic of the BBB requires recapitulating the correct phenotype of the in-vivo BBB, particularly for drug permeation studies. However the majority of widely used BBB models demonstrate low transendothelial electrical resistance (TEER) and poor BBB phenotype. The application of shear stress is known to enhance tight junction formation and hence improve the barrier function. We utilised a high TEER primary porcine brain microvascular endothelial cell (PBMEC) culture to assess the impact of shear stress on barrier formation using the Kirkstall QuasiVivo 600 (QV600) multi-chamber perfusion system. The application of shear stress resulted in a reorientation and enhancement of tight junction formation on both coverslip and permeable inserts, in addition to enhancing and maintaining TEER for longer, when compared to static conditions. Furthermore, the functional consequences of this was demonstrated with the reduction in flux of mitoxantrone across PBMEC monolayers. The QV600 perfusion system may service as a viable tool to enhance and maintain the high TEER PBMEC system for use in in-vitro BBB models.
format Online
Article
Text
id pubmed-7052153
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70521532020-03-06 A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation Elbakary, Basma Badhan, Raj K. S. Sci Rep Article The blood-brain barrier (BBB) serves to protect and regulate the CNS microenvironment. The development of an in-vitro mimic of the BBB requires recapitulating the correct phenotype of the in-vivo BBB, particularly for drug permeation studies. However the majority of widely used BBB models demonstrate low transendothelial electrical resistance (TEER) and poor BBB phenotype. The application of shear stress is known to enhance tight junction formation and hence improve the barrier function. We utilised a high TEER primary porcine brain microvascular endothelial cell (PBMEC) culture to assess the impact of shear stress on barrier formation using the Kirkstall QuasiVivo 600 (QV600) multi-chamber perfusion system. The application of shear stress resulted in a reorientation and enhancement of tight junction formation on both coverslip and permeable inserts, in addition to enhancing and maintaining TEER for longer, when compared to static conditions. Furthermore, the functional consequences of this was demonstrated with the reduction in flux of mitoxantrone across PBMEC monolayers. The QV600 perfusion system may service as a viable tool to enhance and maintain the high TEER PBMEC system for use in in-vitro BBB models. Nature Publishing Group UK 2020-03-02 /pmc/articles/PMC7052153/ /pubmed/32123236 http://dx.doi.org/10.1038/s41598-020-60689-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Elbakary, Basma
Badhan, Raj K. S.
A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
title A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
title_full A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
title_fullStr A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
title_full_unstemmed A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
title_short A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
title_sort dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052153/
https://www.ncbi.nlm.nih.gov/pubmed/32123236
http://dx.doi.org/10.1038/s41598-020-60689-w
work_keys_str_mv AT elbakarybasma adynamicperfusionbasedbloodbrainbarriermodelforcytotoxicitytestinganddrugpermeation
AT badhanrajks adynamicperfusionbasedbloodbrainbarriermodelforcytotoxicitytestinganddrugpermeation
AT elbakarybasma dynamicperfusionbasedbloodbrainbarriermodelforcytotoxicitytestinganddrugpermeation
AT badhanrajks dynamicperfusionbasedbloodbrainbarriermodelforcytotoxicitytestinganddrugpermeation